Victory Capital Management Inc Rocket Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

$95.7 Billion
Q4 2024

A detailed history of Victory Capital Management Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 10,271 shares of RCKT stock, worth $94,595. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,271

Previous 10,637 3.44%

Holding current value

$94,595

Previous $196,000 34.18%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$11.35 - $18.82 $4,154 - $6,888	-366 Reduced 3.44%	10,271 $129,000
Q3 2024 Nov 05, 2024	SELL	$17.6 - $25.88 $3,009 - $4,425	-171 Reduced 1.58%	10,637 $196,000
Q2 2024 Aug 05, 2024	SELL	$20.66 - $26.72 $768,758 - $994,251	-37,210 Reduced 77.49%	10,808 $232,000
Q1 2024 May 03, 2024	BUY	$26.16 - $30.74 $65,661 - $77,157	2,510 Added 5.52%	48,018 $1.29 Million
Q4 2023 Feb 05, 2024	BUY	$16.78 - $31.94 $105,680 - $201,158	6,298 Added 16.06%	45,508 $1.36 Million
Q3 2023 Nov 06, 2023	SELL	$15.07 - $24.05 $103,229 - $164,742	-6,850 Reduced 14.87%	39,210 $803,000
Q2 2023 Jul 27, 2023	BUY	$16.59 - $23.6 $106,341 - $151,276	6,410 Added 16.17%	46,060 $915,000
Q1 2023 May 02, 2023	BUY	$15.79 - $22.6 $626,073 - $896,090	39,650 New	39,650 $679,000
Q4 2021 Feb 07, 2022	SELL	$21.52 - $36.02 $195,100 - $326,557	-9,066 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$27.42 - $48.97 $8,884 - $15,866	-324 Reduced 3.45%	9,066 $271,000
Q2 2021 Aug 03, 2021	BUY	$39.41 - $47.25 $18,010 - $21,593	457 Added 5.12%	9,390 $416,000
Q1 2021 May 04, 2021	BUY	$43.34 - $65.91 $38,269 - $58,198	883 Added 10.97%	8,933 $396,000
Q4 2020 Feb 01, 2021	BUY	$23.3 - $59.57 $187,565 - $479,538	8,050 New	8,050 $441,000
Q2 2020 Aug 07, 2020	SELL	$13.32 - $22.61 $109,730 - $186,261	-8,238 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$9.71 - $25.11 $25,090 - $64,884	-2,584 Reduced 23.88%	8,238 $115,000
Q4 2019 Feb 06, 2020	BUY	$11.07 - $24.23 $33,829 - $74,046	3,056 Added 39.35%	10,822 $246,000
Q4 2019 Feb 04, 2020	SELL	$11.07 - $24.23 $1,239 - $2,713	-112 Reduced 1.42%	7,766 $159,000
Q3 2019 Nov 12, 2019	BUY	$10.85 - $14.78 $85,476 - $116,436	7,878 New	7,878 $92,000

Others Institutions Holding RCKT

# of Institutions

244

Shares Held

108M

Call Options Held

262K

Put Options Held

159K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $697M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Rocket Pharmaceuticals, Inc. Transaction History